Comparative assessment of noninvasive methods (NIMs)-LIVERFASt, liver stiffness measurement (LSM) with transient elastography (TE, Fibroscan) ELF and FiB-4-in a prospective cohort with chronic liver diseases (CLD) from a tertiary liver center

Tangvoraphonkchai, Kawin; Suttichaimongkol, Tanita; Sa-ngaimwibool, Prakasit; Sukeepaisarnjaroen, Wattana; Kularbkaew, Churaieat

doi:10.1016/s0168-8278(22)01326-5

Search citation statements

Order By: Relevance

Paper Sections

Select...

Combined Strategy For Nafld Diagnosis Risk Stratification An...1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was developed as a non-invasive tool for the diagnosis and monitoring of NALFLD, NASH, hepatitis B, and hepatitis C. Its performance in estimating severe fibrosis is similar to TE and better than FIB-4. The applicability of the algorithm could be extended to primary care as a screening tool for NAFLD/NASH in populations at risk, including patients with T2DM [157].…”

Section: Combined Strategy For Nafld Diagnosis Risk Stratification An...mentioning

confidence: 99%

Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations

Boeriu,

Dobru,

Fofiu

2023

Life

View full text Add to dashboard Cite

The progressive potential of liver damage in type 2 diabetes mellitus (T2DM) towards advanced fibrosis, end-stage liver disease, and hepatocarcinoma has led to increased concern for quantifying liver injury and individual risk assessment. The combination of blood-based markers and imaging techniques is recommended for the initial evaluation in NAFLD and for regular monitoring to evaluate disease progression. Continued development of ultrasonographic and magnetic resonance imaging methods for accurate quantification of liver steatosis and fibrosis, as well as promising tools for the detection of high-risk NASH, have been noted. In this review, we aim to summarize available evidence regarding the usefulness of non-invasive methods for the assessment of NAFLD in T2DM. We focus on the power and limitations of various methods for diagnosis, risk stratification, and patient monitoring that support their implementation in clinical setting or in research field.

show abstract

Section: Combined Strategy For Nafld Diagnosis Risk Stratification An...mentioning

confidence: 99%

Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations

Boeriu,

Dobru,

Fofiu

2023

Life

View full text Add to dashboard Cite

show abstract

Comparative assessment of noninvasive methods (NIMs)-LIVERFASt, liver stiffness measurement (LSM) with transient elastography (TE, Fibroscan) ELF and FiB-4-in a prospective cohort with chronic liver diseases (CLD) from a tertiary liver center

Cited by 1 publication

References 0 publications

Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations

Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations

Contact Info

Product

Resources

About